Targeting inflammation in the hypothalamus by the inactivation of IκB kinase or TNFα blockade protects against defective thermogenesis, obesity and IR [15,16], suggesting that hypothalamic dysfunction may precede and mechanistically contribute to obesity-associated IR and Type II diabetes (Type II DM). Here, TNF is linked to obesity due to melanocortin 4 receptor deficiency.